These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7309279)
1. Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth. Kwa HG; Cleton F; Bulbrook RD; Wang DY; Hayward JL Int J Cancer; 1981 Jul; 28(1):31-4. PubMed ID: 7309279 [TBL] [Abstract][Full Text] [Related]
2. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Hayward JL; Gravelle IH Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1225-31. PubMed ID: 3416905 [TBL] [Abstract][Full Text] [Related]
3. The relationship between blood prolactin levels and risk of breast cancer in premenopausal women. Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Chaudary M; Hayward JL Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1541-8. PubMed ID: 3678318 [TBL] [Abstract][Full Text] [Related]
4. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Eliassen AH; Tworoger SS; Hankinson SE Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859 [TBL] [Abstract][Full Text] [Related]
5. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk. Kampert JB; Whittemore AS; Paffenbarger RS Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296 [TBL] [Abstract][Full Text] [Related]
6. Nyctohemeral changes in plasma prolactin levels and their relationship to breast cancer risk. Wang DY; Sturzaker HE; Kwa HG; Verhofstad F; Hayward JL; Bulbrook RD Int J Cancer; 1984 May; 33(5):629-32. PubMed ID: 6724738 [TBL] [Abstract][Full Text] [Related]
7. Relationship of blood prolactin levels and the risk of subsequent breast cancer. Wang DY; De Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Fentiman IS; Hayward JL; Millis RR Int J Epidemiol; 1992 Apr; 21(2):214-21. PubMed ID: 1428472 [TBL] [Abstract][Full Text] [Related]
8. Relation between tumour size and plasma prolactin levels in premenopausal patients with breast carcinoma. A preliminary report. Olsson H; Ewers SB; Landin-Olsson M; Ranstam J Acta Radiol Oncol; 1985; 24(1):57-9. PubMed ID: 2984903 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease. Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323 [TBL] [Abstract][Full Text] [Related]
10. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer. Love RR; Rose DR; Surawicz TS; Newcomb PA Cancer; 1991 Sep; 68(6):1401-5. PubMed ID: 1873792 [TBL] [Abstract][Full Text] [Related]
11. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer. Kwa HG; Wang DY Int J Cancer; 1977 Jul; 20(1):12-4. PubMed ID: 561758 [TBL] [Abstract][Full Text] [Related]
12. Prolactin and breast cancer risk. Ingram DM; Nottage EM; Roberts AN Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338 [TBL] [Abstract][Full Text] [Related]
13. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age. Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773 [TBL] [Abstract][Full Text] [Related]
14. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. Hankinson SE; Willett WC; Manson JE; Hunter DJ; Colditz GA; Stampfer MJ; Longcope C; Speizer FE J Natl Cancer Inst; 1995 Sep; 87(17):1297-302. PubMed ID: 7658481 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for breast cancer in women undergoing mammography. Reuter KL; Baker SP; Krolikowski FJ AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780 [TBL] [Abstract][Full Text] [Related]
16. Plasma prolactin and its relationship to risk factors in human breast cancer. Kwa HG; Cleton F; de Jong-Bakker M; Bulbrook RD; Hayward JL; Wang DY Int J Cancer; 1976 Apr; 17(4):441-7. PubMed ID: 945228 [TBL] [Abstract][Full Text] [Related]
17. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment. de Waard F; Kwa HG; Poortman J Oncology; 1980; 37(1):33-6. PubMed ID: 7350553 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for breast cancer. Helmrich SP; Shapiro S; Rosenberg L; Kaufman DW; Slone D; Bain C; Miettinen OS; Stolley PD; Rosenshein NB; Knapp RC; Leavitt T; Schottenfeld D; Engle RL; Levy M Am J Epidemiol; 1983 Jan; 117(1):35-45. PubMed ID: 6823951 [TBL] [Abstract][Full Text] [Related]
19. Plasma prolactin levels in patients with breast cancer. Rose DP; Pruitt BT Cancer; 1981 Dec; 48(12):2687-91. PubMed ID: 7306924 [TBL] [Abstract][Full Text] [Related]
20. Sociodemographic factors and pregnancy outcomes associated with prepregnancy obesity: effect modification of parity in the nationwide Epifane birth-cohort. Boudet-Berquier J; Salanave B; Desenclos JC; Castetbon K BMC Pregnancy Childbirth; 2017 Aug; 17(1):273. PubMed ID: 28841845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]